Academician
YUNUS EMRE EKŞİ
Doktor Öğretim Üyesi
Alanya Alaaddin Keykubat Üniversitesi
- CRISPR and Genetic Engineering3
- Virus-based gene therapy research2
- SARS-CoV-2 and COVID-19 Research1
- Inflammasome and immune disorders1
- Pancreatic function and diabetes1
- Peptidase Inhibition and Analysis1
- Animal Virus Infections Studies1
- Viral gastroenteritis research and epidemiology1
- Diabetes and associated disorders1
- CAR-T cell therapy research1
- Neuropeptides and Animal Physiology1
- Adipose Tissue and Metabolism1
Citation impact
OpenAlex YÖKSİS articles matched in OpenAlex: 7 + YÖKSİS · co-author record: 1- i10-index
- 5
- Total citations
- 164 Top 29% in Türkiye
- Per article
- 20.5
- FWCI
- 5.17 1.00 = world average
- World top 1%
- 1
- World top 10%
- 3
Most cited articles
How is this computed?
h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included. 1 articles (5 citations) tagged with this academic’s YÖK author id in co-authors’ YÖKSİS records count only towards citations, h-index and i10; article counts, percentiles and rankings use their own YÖKSİS list.
Citing publications
Crossref 26 publications citing 7 DOI-bearing articles · 5 Türkiye-affiliated2019 22020 12021 92022 22025 112026 1
- 10.1016/j.pharmthera.2025.108958 2026
- Lantidra (donislecel) in type 1 diabetes: An in‐depth analysis of pharmacology, clinical effectiveness, safety, and the therapeutic role of the first <scp>FDA</scp> ‐approved allogeneic islet cell therapy TR Ezgi Erbasan et al. · Diabetic Medicine · 2025
- 10.1093/ejendo/lvaf231 2025
- 10.3390/dna5040057 2025
- 10.64898/2025.12.02.690677 2025
- 10.1038/s41409-025-02774-0 2025
- 10.1016/j.cels.2025.101425 2025
- 10.25176/rfmh.v25i3.7862 2025
- 10.1097/ms9.0000000000004274 2025
- 10.1186/s13287-025-04781-w 2025
- 10.55095/cspediatrie2025/050 2025
- 10.1101/2025.11.10.687670 2025
- 10.3390/vaccines10020295 2022
- 10.32604/biocell.2022.017853 2022
- Lentivirus Mediated Pancreatic Beta-Cell-Specific Insulin Gene Therapy for STZ-Induced Diabetes TR Fulya Erendor et al. · Molecular Therapy · 2021
- Current Update on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development with a Special Emphasis on Gene Therapy Viral Vector Design and Construction for Vaccination TR Atil Bisgin et al. · Human Gene Therapy · 2021 · cites 2 articles of this academic
- Genome engineering and disease modeling <i>via</i> programmable nucleases for insulin gene therapy; promises of CRISPR/Cas9 technology TR Yunus E Eksi et al. · World Journal of Stem Cells · 2021
- 10.1016/j.bcp.2021.114809 2021
- 10.1016/j.ijbiomac.2021.05.192 2021
- 10.1142/s2737566821500018 2021
- 10.1186/s40779-021-00360-1 2021
- 10.1016/j.medj.2021.09.001 2021
- 10.3390/vaccines9080848 2021
- Lentiviral gene therapy vectors encoding VIP suppressed diabetes-related inflammation and augmented pancreatic beta-cell proliferation TR Fulya Erendor et al. · Gene Therapy · 2020
- 10.1080/13102818.2019.1643783 2019
- 10.34019/1982-8047.2018.v44.14053 2019
Where does this list come from?
Extracted from the reference lists in Crossref’s public March 2026 data file; 18.4% of the file has been processed, so the list may be incomplete. Crossref citations are never added to or compared with the OpenAlex citation counts; the two sources have different coverage.
Collaboration network
From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.
- Co-authors
- 20
- With an akaturk profile
- 9
- Turkish institutions
- 6
- Co-authored works
- %100
Academic co-authors 9
- SALİH ŞANLIOĞLU Profesör · Akdeniz Üniversitesi 7
- AHTER DİLŞAD ŞANLIOĞLU Profesör · Akdeniz Üniversitesi 5
- FULYA ERENDOR CİHAN Doktor Öğretim Üyesi · Ordu Üniversitesi 3
- DENİZ ARCA ÇAKIR Araştırma Görevlisi · Hacettepe Üniversitesi 1
- DURKADIN DEMİR EKŞİ Doçent · Alanya Alaaddin Keykubat Üniversitesi same university 1
- GÜLAY GÜLBOL DURAN Doçent · Hatay Mustafa Kemal Üniversitesi 1
- HAYRİYE ARZU ERGEN Profesör · İstanbul Üniversitesi 1
- MUHAMMET MURAT ÇELİK Profesör · Siirt Üniversitesi 1
- RAMAZAN GÜNEŞAÇAR Profesör · Hatay Mustafa Kemal Üniversitesi 1
National collaboration 6 institutions
Within own university1 joint works · Alanya Alaaddin Keykubat Üniversitesi
- Akdeniz Üniversitesi 7 works · 2 academics
- Ordu Üniversitesi 3 works · 1 academics
- Hacettepe Üniversitesi 1 works · 1 academics
- Hatay Mustafa Kemal Üniversitesi 1 works · 2 academics
- Siirt Üniversitesi 1 works · 1 academics
- İstanbul Üniversitesi 1 works · 1 academics
Other co-authors (incl. international) 11
Thomas Griffith 3Büşra Çetin 2MUSTAFA KEMAL BALCI 2ATIL BİŞGİNBahar AkkayaELİF ÖZGECAN ŞAHİNErmiş Karaali ZeynepEsin Bilge ÖztürkHASAN ALİ ALTUNBAŞIncekara KutluhanMükerrem Hale Taşyürek
Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.
Indexes and citation percentiles
?Other counts
Scopus (SJR)
- YÖKSİS rows 9
WoS (JCR)
- YÖKSİS rows 8
Articles
Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.
Journals with publications
9 journals
Narrow down
Article list
- 2025 The Role of Energy Homeostasis-Associated Gene Expression and Serum Adropin Levels in Patients with Familial Mediterranean Fever YÖKSİS SJR Q1 JCR Q1 OpenAlex 2.2%
- 2025 Advancing CRISPR genome editing into gene therapy clinical trials: progress and future prospects YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.8%
- 2024 Gene and cell therapy of human genetic diseases: Recent advances and future directions YÖKSİS SJR Q2 JCR Q2 OpenAlex top 10% OpenAlex 96.5%
- 2021 Lentivirus Mediated Pancreatic Beta-Cell-Specific Insulin Gene Therapy for STZ-induced Diabetes YÖKSİS SJR Q1 JCR Q1 OpenAlex 89.5%
- 2021 Current Update on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development with a Special Emphasis on Gene Therapy Viral Vector Design and Construction for Vaccination. YÖKSİS SJR Q2 JCR Q1 OpenAlex 73.4%
- 2021 Genome engineering and disease modeling via programmable nucleases for insulin gene therapy; promises of CRISPR/Cas9 technology YÖKSİS SJR Q2 JCR Q2 OpenAlex 55.1%
- 2018 HIV-based lentivirus-mediated vasoactive intestinal peptide gene delivery protects against DIO animal model of Type 2 diabetes YÖKSİS SJR Q2 JCR Q1 OpenAlex 69.1%
- 2016 TVEC YÖKSİS TR Index SJR Q4
- 2014 Myeloperoxidase And Glutamate Cysteine Ligase Polymorphisms In Type 2 Diabetes Mellitus A Preliminary Study YÖKSİS SJR Q3 JCR Q4